What is PatientsLikeMe?
Founded in 2004 and headquartered in Boston, Massachusetts, PatientsLikeMe operates as a sophisticated patient network and real-time research platform. By facilitating direct connections between individuals sharing similar medical conditions, the company enables the aggregation of experiential data that is critical for advancing medical research. This unique model bridges the gap between patient advocacy and clinical insight, positioning the firm as a vital intermediary in the digital health landscape. The company leverages this data to provide actionable intelligence, effectively transforming personal health narratives into structured, research-grade information that supports both pharmaceutical development and improved patient outcomes.
How much funding has PatientsLikeMe raised?
PatientsLikeMe has raised a total of $156M across 7 funding rounds:
Series A
$5M
Private Equity
$8M
Private Equity
$12M
Private Equity
$3M
Private Equity
$2M
Private Equity
$100M
Other Financing Round
$26M
Series A (2007): $5M with participation from Invus, CommerceNet, and Omidyar Network
Private Equity (2010): $8M, investors not publicly disclosed
Private Equity (2012): $12M, investors not publicly disclosed
Private Equity (2012): $3M, investors not publicly disclosed
Private Equity (2013): $2M, investors not publicly disclosed
Private Equity (2017): $100M with participation from iCarbonX and Invus
Other Financing Round (2021): $26M led by Alta Partners LLC, PBM Capital, Optum Ventures, and Hambrecht Ducera Growth Ventures
Key Investors in PatientsLikeMe
iCarbonX
A digital health pioneer focused on building a global platform for digitizing and analyzing life through multi-omics and artificial intelligence.
Invus
An established investment firm founded in 1985, providing strategic financial advice and capital to support long-term growth initiatives.
Optum Ventures
The venture capital arm of Optum, specializing in early-stage investments in companies poised to disrupt the healthcare status quo.
What's next for PatientsLikeMe?
The recent capital injection signals a pivotal phase for PatientsLikeMe as it seeks to deepen its integration with enterprise-level healthcare stakeholders. By leveraging its extensive longitudinal data sets, the company is well-positioned to capitalize on the growing demand for real-world evidence in drug development and personalized medicine. Future strategic initiatives will likely focus on enhancing the platform's analytical capabilities, expanding its multi-omics data integration, and fostering deeper partnerships with health systems to drive innovation in condition management and preventative care. As the digital health market matures, PatientsLikeMe remains a critical asset for organizations aiming to digitize and understand the complexities of human health at scale.
See full PatientsLikeMe company page
